Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 3, 1997, Pages 617-623

  Moran, Gary P ^a,b   Sullivan, Derek J ^a   Henman, Martin C ^a   McCreary, Christine E ^a   Harrington, Barry J ^a   Shanley, Diarmuid B ^a   Coleman, David C ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b DUBLIN DENTAL UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; DNA FINGERPRINTING; DRUG SENSITIVITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KARYOTYPING; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; THRUSH;

EID: 0031018791     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.3.617     Document Type: Article

References (30)

1. Berrouane, Y. F., R. J. Hollis, and M. A. Pfaller. 1996. Strain variation among and antifungal susceptibilities of isolates of Candida krusei. J. Clin. Microbiol. 34:1856-1858.
2. Boerlin, P., F. Boerlin-Petzold, C. Durussel, M. Addo, J.-L. Pagani, J.-P. Chave, and J. Bille. 1995. Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users. J. Clin. Microbiol. 33:1129-1135.
3. Coleman, D., and D. Sullivan. Unpublished data.
4. Coleman, D. C., D. E. Bennett, D. J. Sullivan, P. J. Gallagher, M. C. Henman, D. B. Shanley, and R. J. Russell. 1993. Oral Candida in HIV infection and AIDS: new perspectives/new approaches. Crit. Rev. Microbiol. 19:61-82.
5. Colombo, A. L., F. Barchiesi, D. A. McGough, and M. G. Rinaldi. 1995. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing. J. Clin. Microbiol. 33:535-540.
6. Fisher-Hoch, S. P., and L. Hutwanger. 1995. Opportunistic candidiasis: an epidemic of the 1980's. Clin. Infect. Dis. 21:897-904.
7. Galgiani, J. N., and D. A. Stevens. 1976. Antimicrobial susceptibility of yeasts: a turbidimetric technique independent of inoculum size. Antimicrob. Agents Chemother. 10:721-726.
8. Gallagher, P. J., D. E. Bennett, M. C. Henman, R. J. Russell, S. R. Flint, D. B. Shanley, and D. C. Coleman. 1992. Reduced azole susceptibility of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation. J. Gen. Microbiol. 138:1901-1911.
9. Hazen, K. C. 1995. New and emerging yeast pathogens. Clin. Microbiol. Rev. 8:462-478.
10. Johnson, E. M., and D. W. Warnock. 1995. Azole drug resistance in yeasts. J. Antimicrob. Chemother. 36:751-755.
11. Lockhart, S. R., J. J. Fritch, A. Sturdevant Meier, K. Schröppel, T. Srikantha, R. Galask, and D. R. Soll. 1995. Colonizing populations of Candida albicans are clonal in origin but undergo microevolution through Cl fragment reorganization as demonstrated by DNA fingerprinting and Cl sequencing. J. Clin. Microbiol. 33:1501-1509.
12. McCullough, M., B. Ross, and P. Reade. 1995. Characterization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with human immunodeficiency virus. J. Clin. Microbiol. 33:696-700.
13. McCullough, M. J., B. C. Ross, B. D. Dwyer, and P. C. Reade. 1994. Genotype and phenotype of oral Candida albicans from patients infected with the human immunodeficiency virus. Microbiology 140:1195-1202.
14. National Committee for Clinical Laboratory Standards. 1992. Reference method for broth dilution antifungal susceptibility testing for yeasts. Proposed standard M27-P. National Committee for Clinical Laboratory Standards, Villanova, Pa.
15. Pfaller, M., and R. Wenzel. 1992. Impact of the changing epidemiology of fungal infections in the 1990's. Eur. J. Clin. Microbiol. Infect. Dis. 11:287-291.
16. Pfaller, M. A. 1994. Epidemiology and control of fungal infections. Clin. Infect. Dis. 19(Suppl. 1):S8-S13.
17. Pfaller, M. A. 1996. Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin. Infect. Dis. 22(Suppl. 2):S89-S94.
18. Rex, J. H., C. R. Cooper, Jr., W. G. Merz, J. N. Galgiani, and E. J. Anaissie. 1995. Detection of amphotericin B-resistant Candida isolates in a broth-based system. Antimicrob. Agents Chemother. 39:906-909.
19. Rodriguez-Tudela, J. L., and J. V. Martinez-Suárez. 1995. Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria. J. Antimicrob. Chemother. 35:739-749.
20. Sanglard, D., K. Kuchler, F. Ischer, J.-L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
21. Scherer, S., and D. A. Stevens. 1988. A Candida albicans dispersed, repeated gene family and its epidemiologic applications. Proc. Natl. Acad. Sci. USA 85:1452-1456.
22. Sullivan, D., D. Bennett, M. Henman, P. Harwood, S. Flint, F. Mulcahy, D. Shanley, and D. Coleman. 1993. Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients. J. Clin. Microbiol. 31:2124-2133.
23. Sullivan, D., K. Haynes, G. Moran, D. Shanley, and D. Coleman. 1996. Persistence, replacement, and microevolution of Cryptococcus neoformans strains in recurrent meningitis in AIDS patients. J. Clin. Microbiol. 34:1739-1744.
24. Sullivan, D. J., M. C. Henman, G. P. Moran, L. C. O'Neill, D. E. Bennett, D. B. Shanley, and D. C. Coleman. 1996. Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species. J. Med. Microbiol. 44:399-408.
25. Sullivan, D. J., T. J. Westerneng, K. A. Haynes, D. E. Bennett, and D. C. Coleman. 1995. Candida dubliniensis sp. nov.: phenotypic and molecular characterisation of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 141:1507-1521.
26. Valentin, A., R. Le Guennec, E. Rodriguez, J. Reynes, M. Mallie, and J.-M. Bastide. 1996. Comparative resistance of Candida albicans clinical isolates to fluconazole and itraconazole in vitro and in vivo in a murine model. Antimicrob. Agents Chemother. 40:1342-1345.
27. Vanden Bossche, H., P. Marichal, J. Gorrens, D. Bellens, H. Moereels, and P. A. J. Janssen. 1990. Mutation in cytochrome P-450-dependent 14α-demethylase results in decreased affinity for azole antifungals. Biochem. Soc. Trans. 18:56-59.
28. Vanden Bossche, H., P. Marichal, and F. C. Odds. 1994. Molecular mechanisms of drug resistance in fungi. Trends Microbiol. 2:393-400.
29. Vazquez, J. A., A. Beckley, J. D. Sobel, and M. J. Zervos. 1991. Comparison of restriction enzyme analysis and pulsed-field gradient gel electrophoresis as typing systems for Candida albicans. J. Clin. Microbiol. 29:962-967.
30. Warnock, D. W. 1992. Azole drug resistance in Candida species. J. Med. Microbiol. 37:225-226.